High risk of venous thromboembolism after orthopedic surgery in patients with thrombophilia. (5th January 2021)

• Record Type: Journal Article
• Authors: Zambelli, Roberto; Nemeth, Banne; Touw, Carolina E.; Rosendaal, Frits R.; Rezende, Suely M.; Cannegieter, Suzanne C.
• Is Part Of: Journal of thrombosis and haemostasis. Volume 19:Number 2(2021)
• Page Start: 444
• Page End: 451
• Publication Date: 2021-01-05
• Subjects: factor V Leiden -- orthopaedic surgery -- risk -- thrombophilia -- venous thromboembolism; Thrombosis -- Periodicals; Hemostasis -- Periodicals; Blood coagulation disorders -- Periodicals; 616.1
• DOI: 10.1111/jth.15163
• Languages: English
• ISSNs: 1538-7933

Abstract

Abstract: Objective: This study aimed at evaluating the effect of thrombophilia on the risk of venous thromboembolism (VTE) in patients undergoing any type of orthopedic surgery. Background: Patients undergoing orthopedic surgery are at high risk for VTE. Although patients with thrombophilia have an increased risk of VTE, it is currently unclear whether there is a synergetic effect in patients with thrombophilia who undergo orthopedic surgery. Methods: Data from a large population‐based case–control study (the Multiple Environmental and Genetic Assessment [MEGA] of risk factors for venous thrombosis study) were used. Odds ratios (ORs) with 95% confidence intervals (CIs), adjusted for age, sex, and body mass index (BMI) (ORadj) were calculated for patients undergoing any orthopedic intervention. Results: Of 4721 cases and 5638 controls, 263 cases and 94 controls underwent orthopedic surgery. Patients who had any orthopedic intervention in the year before the index date were at higher risk of VTE (ORadj 3.7; 95% CI, 2.9‐4.8) than those who did not undergo any orthopedic surgery. There was an additionally increased risk in patients with factor V Leiden (OR 17.5, 95% CI, 4.1‐73.6), non‐O blood group (OR 11.2; 95% CI, 3.4‐34.0), or elevated plasma levels of factor VIII (OR 18.6; 95% CI, 7.4‐46.9) all relative to patients without these defects, not undergoing orthopedic surgery. Conclusions: Patients with factor V Leiden, high levels of factor VIII, or blood group non‐O were found to have a high risk of VTE after orthopedic surgery. Identification of these patients may enable individualized thromboprophylactic treatment to efficiently reduce VTE risk.